Arrowstreet Capital, Limited Partnership Bio N Tech Se Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $8.26 Million - $10.4 Million	-67,358 Reduced 39.2%	104,491 $13 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $20.4 Million - $32 Million	171,849 New	171,849 $25.8 Million
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $708,136 - $1.3 Million	-5,609 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $8.7 Million - $14.6 Million	-40,165 Reduced 87.75%	5,609 $1.45 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $9.43 Million - $20.5 Million	45,774 New	45,774 $12.5 Million

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.